Cargando…
ESBLs: A Clear and Present Danger?
Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher mo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135063/ https://www.ncbi.nlm.nih.gov/pubmed/21766013 http://dx.doi.org/10.1155/2012/625170 |
_version_ | 1782208051166576640 |
---|---|
author | Dhillon, Rishi H.-P. Clark, John |
author_facet | Dhillon, Rishi H.-P. Clark, John |
author_sort | Dhillon, Rishi H.-P. |
collection | PubMed |
description | Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher morbidity and mortality and greater fiscal burden. Coupled with increasing prevalence rates worldwide and an ever diminishing supply in the antibiotic armamentarium, these enzymes represent a clear and present danger to public health. This article aims to give an overview of the current situation regarding ESBLs, with a focus on the epidemiology and management of such infections. |
format | Online Article Text |
id | pubmed-3135063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31350632011-07-15 ESBLs: A Clear and Present Danger? Dhillon, Rishi H.-P. Clark, John Crit Care Res Pract Review Article Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher morbidity and mortality and greater fiscal burden. Coupled with increasing prevalence rates worldwide and an ever diminishing supply in the antibiotic armamentarium, these enzymes represent a clear and present danger to public health. This article aims to give an overview of the current situation regarding ESBLs, with a focus on the epidemiology and management of such infections. Hindawi Publishing Corporation 2012 2011-06-06 /pmc/articles/PMC3135063/ /pubmed/21766013 http://dx.doi.org/10.1155/2012/625170 Text en Copyright © 2012 R. H.-P. Dhillon and J. Clark. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Dhillon, Rishi H.-P. Clark, John ESBLs: A Clear and Present Danger? |
title | ESBLs: A Clear and Present Danger? |
title_full | ESBLs: A Clear and Present Danger? |
title_fullStr | ESBLs: A Clear and Present Danger? |
title_full_unstemmed | ESBLs: A Clear and Present Danger? |
title_short | ESBLs: A Clear and Present Danger? |
title_sort | esbls: a clear and present danger? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135063/ https://www.ncbi.nlm.nih.gov/pubmed/21766013 http://dx.doi.org/10.1155/2012/625170 |
work_keys_str_mv | AT dhillonrishihp esblsaclearandpresentdanger AT clarkjohn esblsaclearandpresentdanger |